April 3, 2025 - 16:51

The recent decision to withhold Title X funding has sent shockwaves through approximately 50 clinical sites in Western Pennsylvania. According to a vice president at Adagio Health, the impact of these cuts will be felt deeply in the community, as many clinics rely on this federal funding to provide essential health services.
Title X is a crucial program that supports family planning and preventive health services, including contraceptive services, cancer screenings, and STI testing and treatment. The reduction in funding poses significant challenges for clinics, which may struggle to maintain their services and support for low-income individuals and families.
Health care providers are now faced with the daunting task of finding alternative funding sources to fill the gap left by the cuts. This situation raises concerns about access to critical health care services for vulnerable populations in the region. As clinics prepare to navigate these changes, the future of reproductive health services in Western Pennsylvania remains uncertain.
March 31, 2026 - 08:40
SF Supervisor Jackie Fielder on leave due to mental health condition; her staff set to take overSan Francisco Supervisor Jackie Fielder is taking a temporary leave of absence from her official duties to address a mental health condition, her office confirmed this week. The announcement...
March 30, 2026 - 19:56
CVS Health puts creative and media in reviewCVS Health has launched a comprehensive review of its creative and media agency partnerships, a significant move that puts its substantial advertising account under scrutiny. This decision comes as...
March 30, 2026 - 15:51
New £1.5m research facility plan for New Cross HospitalA major £1.5 million investment is set to establish a new clinical research facility at New Cross Hospital, a move heralded by NHS leaders as a significant advancement for patient care, medical...
March 29, 2026 - 18:52
Makers of dietary supplements push the FDA to allow peptides and other new ingredientsThe dietary supplement industry is actively urging the U.S. Food and Drug Administration to modernize its regulatory approach to allow novel ingredients, including peptides and other compounds,...